Metropolis Healthcare Ltd
NSE: METROPOLIS BSE: 542650
₹1947.80
(-1.99%)
Sat, 14 Feb 2026, 00:45 pm
Market Cap100.91B
PE Ratio60.20
Dividend0.21
Health Services
Medical/Nursing Services
24.5KMetropolis Healthcare Analysis
dividend
- Dividends paid are well covered by earnings (3.2x coverage).
- Dividends after 3 years are expected to be covered by earnings (1.8x coverage).
- Metropolis Healthcare only just started paying a dividend, it is too early to tell if payments are increasing.
- It is too early to tell whether Metropolis Healthcare has stable dividend payments.
- Metropolis Healthcare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Metropolis Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
future
- Metropolis Healthcare's earnings are expected to grow significantly at over 20% yearly.
- Metropolis Healthcare's earnings growth is expected to exceed the India market average.
- Metropolis Healthcare's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Metropolis Healthcare's earnings are expected to increase by more than the low risk growth rate in 3 years time.
- Metropolis Healthcare's net income is expected to increase by more than 50% in 2 years time.
- Metropolis Healthcare is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
- Performance (ROE) is expected to be above the current IN Healthcare industry average.
- An improvement in Metropolis Healthcare's performance (ROE) is expected over the next 3 years.
- Metropolis Healthcare's revenue growth is expected to exceed the India market average.
- Cash flow for Metropolis Healthcare is expected to increase but not above the 50% threshold in 2 years time.
- Metropolis Healthcare's earnings are expected to decrease over the next year.
- Metropolis Healthcare's revenue is expected to increase but not above the 50% threshold in 2 years time.
- Metropolis Healthcare's revenue is expected to grow by 13.7% yearly, however this is not considered high growth (20% yearly).
health
- Metropolis Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Metropolis Healthcare is profitable, therefore cash runway is not a concern.
- Metropolis Healthcare is profitable, therefore cash runway is not a concern.
- Metropolis Healthcare's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (5% vs 0% today).
- Metropolis Healthcare has no debt, therefore coverage of interest payments is not a concern.
- Metropolis Healthcare's level of debt (0%) compared to net worth is satisfactory (less than 40%).
- Operating cash flow is negative therefore debt is not well covered.
- Debt is not covered by short term assets, assets are -3.492571417742E+16x debt.
- High level of physical assets or inventory.
management
- The tenure for the Metropolis Healthcare management team is about average.
- The average tenure for the Metropolis Healthcare board of directors is less than 3 years, this suggests a new board.
- Metropolis Healthcare individual insiders have only sold shares in the past 3 months.
past
- Metropolis Healthcare's year on year earnings growth rate has been positive over the past 5 years.
- Metropolis Healthcare used its assets more efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Metropolis Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Metropolis Healthcare's 1-year earnings growth is less than its 5-year average (5.9% vs 13.5%)
- Metropolis Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Metropolis Healthcare's earnings growth has not exceeded the IN Healthcare industry average in the past year (5.9% vs 14.4%).
value
- 542650 outperformed the Healthcare industry which returned 9.1% over the past year.
- 542650 outperformed the Market in India which returned -14.5% over the past year.
- BSE:542650 is up 12.3% outperforming the Healthcare industry which returned 5.4% over the past month.
- BSE:542650 is up 12.3% outperforming the market in India which returned 8% over the past month.
- Metropolis Healthcare's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Metropolis Healthcare's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Metropolis Healthcare is overvalued based on assets compared to the IN Healthcare industry average.
- Metropolis Healthcare is poor value based on expected growth next year.
- Metropolis Healthcare is overvalued based on earnings compared to the IN Healthcare industry average.
- Metropolis Healthcare is overvalued based on earnings compared to the India market.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800